The Kennel Club has announced that the Crufts Best of Breed (BOB) winners in two of the high profile breeds - the bulldog and the Pekingese - failed their veterinary checks, so the breeds were not represented in the utility and toy group judging.
The British Veterinary Association says it welcomed the Kennel Club's initiative to put the veterinary checks in place for the BOB winner in the 15 high profile breeds at all championship dog shows starting at Crufts this year.
The 15 breeds have been identified as having particular health problems often due to poor conformation as a result of having been bred with exaggerated characteristics. The veterinary checks ensure the BOB winners are not suffering as a result of their conformation, such as eye problems, skin disease, lameness or breathing difficulties, which should have been identified by the judge.
Carl Padgett, President of the BVA, said: "Breeding dogs with exaggerated features must be tackled robustly. The veterinary checks are sending out a strong message that dogs with health problems will not win in the show ring, and only visibly healthy dogs will be rewarded.
"Dog showing can be a force for good for dog breeding and education but the veterinary checks on the first two groups at Crufts have highlighted the health problems that all too often affect man's best friend.
"We hope this strong action by the Kennel Club will be a wake-up call to those breeders and judges that still need to embrace the message that health should always be at the top of the agenda."
A short film about Ami Sawran MRCVS, who simultaneously works as a vet, an actress and the editor of a lesbian magazine called Reprobait, is being released in Vue West End and Vue Piccadilly cinemas from today.
The film, being shown ahead of big screen blockbusters, is part of a series which make up 1000 Londoners, a project to create a digital portrait of the city.
Each film dips into the life of a Londoner for three minutes. The first ten films being shown over the next two months include one about an entrepreneurial hula-hooper from Hoxton, another featuring the last cloth trader in Shoreditch, one about a cage-fighter on the day of his first professional fight and another about a Big Issue seller who works on the Strand.
Rachel Wang, director of 1000 Londoners, said: “This release gives the people of London an opportunity to see these fascinating documentaries in the greatest way to watch any film in London – on the big screen in the West End. By making this possible Vue Entertainment have been extremely open and forward-thinking in their programming.”
The 1000 Londoners films are currently being released weekly on 1000londoners.com The latest film "Danny" looks below the city into Bazalgette's Victorian sewers, where professional 'flusher' Danny Brackley works. Forthcoming Londoners include an ex-SAS author, a third generation blacksmith from Stepney and a woman who has withdrawn from mainstream society to live on a canal boat.
The strange phenomenon was spotted by Veterinary Vision's clinical director Chris Dixon when he examined Dachshund called Margo, which had been referred for the treatment of a corneal ulcer and fungal infection.
Chris said: “I was assessing Margo’s eye and was very surprised to see a face smiling back at me.
"It perhaps doesn't bear quite the same resemblance as the Turin Shroud. Still, I've never seen anything like it before.
"The good news is that it does not appear to have affected her vision at all.”
Apparently the smiling face is still there, even after Chris performed a corneal graft.
Chris added: "I think we can safely say that Margo is a very happy dog, both inside and out!"
Available for download now, the MobiVet Veterinary Formulary App is designed to make drug calculations and prescribing faster, easier and safer. It contains dose rate and interval data for over 250 drugs commonly used in small animal practice.
Searchable by drug name or trade names, with species-specific dosing information, the app calculates doses based on the patient type, weight, or body surface area as appropriate. MobiVet also provides a checklist of known relevant drug interactions for each medication, to prevent prescribing errors.
Stuart says an iOS version is in production.
To download the Android version, visit: https://play.google.com/store/apps/details?id=com.project.user.drug_formulary&hl=en
Bayer Animal Health (makers of Advocate, Advantix, Advantage, Seresto, Profender, Drontal and Droncit) has launched 'It's a Jungle Out There', an educational initiative aimed at simplifying parasite control for veterinary practices and pet owners alike.
The impressive-looking initiative comes on the back of research carried out by the company which found:
Dan White, Group Product Manager for Bayer's Animal Health division said: "Our research concluded that many vet practices are missing an opportunity because of a lack of clarity regarding best practice for parasite control. With ongoing support and practical development tools, Bayer's 'It's a Jungle Out There' Programme is an educational initiative which will arm vet practices with the tools they need to make parasite control clearer and more accessible to owners, helping to ensure the UK is a nation of healthy parasite-free pets and happy owners."
Bayer says the first stage of the 'It's a Jungle Out There' initiative aims to help the veterinary community identify opportunities where they can help to improve pet owner compliance. Vet practices will then be supported in developing a parasite protocol which will then be launched to consumers via a heavyweight advertising and PR campaign.
The initiative comprises a new educational website: www.jungleforvets.co.uk, which includes practice development workbooks, market research and trends, extensive technical information on a wide variety of parasites and CPD assessments. Additional downloadable content includes a range of materials such as images, videos, downloads and web buttons.
From the end of August, practice support materials will be available including a waiting room display pack, parasite guide and dispenser, vet nurse reference guide, waiting room posters, lifestyle questionnaire, badges and static window stickers.
The pet owner focus will begin in September and will include an interactive website, advertising and an extensive print and broadcast PR campaign with celebrity ambassadors David Bellamy and TV vet Steve Leonard. This activity is aimed at driving owners towards their vet practice for advice on parasite risks.
References
Severn Edge was formed six years ago with the merger of two long-standing neighbouring practices, and now employs 135 people, including 43 veterinary surgeons.
Mrs Karyn MacKenzie, Director of CVS’ Practice Division, said: "Severn Edge is an impressive practice with an outstanding leadership team and an ambitious and exciting vision for the future which we share. We are delighted to welcome the team to CVS and look forward to working with them to help them build an even more successful future."
Dr John Brentnall BVSc MRCVS, a Director of Severn Edge, will continue in the role of CVS Regional Director. He said: "It was clear from our early discussions that CVS understood what we are trying to achieve. We have embarked on a significant investment programme, including upgrading our surgery at Madeley outside Telford, and the redevelopment of the site of an additional clinic which we have recently acquired in Craven Arms.
"In order for us to continually upgrade our clinics, provide the widest range of career opportunities for our staff and steer our practice through an increasingly competitive world, we believe that the best interests of us all lie in joining forces with CVS. It is known for its interest in equine and farm practice, as well as companion animal practice, and has a policy of significant investment in both infrastructure and staff. We believe it offers the best fit with Severn Edge."
The newsletter will include anaesthesia updates, bulletins and recaps, access to videos and downloadable resources.
Articles in Anaesthesia1ST are being written by Jurox’s technical advisors in collaboration with anaesthesia specialists such as Carl Bradbrook (European Veterinary Specialist in Anaesthesia and Analgesia and an RCVS Recognised Specialist in Veterinary Anaesthesia) and Ian Self (European Specialist in Veterinary Anaesthesia and Analgesia, Associate Professor in Veterinary Anaesthesia and Analgesia, Faculty of Medicine & Health Sciences, University of Nottingham).
The first newsletter launched on 15th May and included: ‘Capnography I – not just a load of hot air’, ‘Perspectives on premeds – Alpha-2 agonists’ and ‘What’s new in anaesthesia? Highlights of recent preoxygenation paper’.
Articles in future editions will include: ‘Capnography II – what happened to the elephants?’, ‘Pain, what a pain! Local and regional nerve blocks improve outcomes and welfare of patients’, “The Big Chill – temperature management in sedated and anaesthetised patients’ and ‘Perspectives on premeds – a complete series of articles covering the ins and outs of the different agents, how they compare and recommended use in the different patient types’.
Jurox says that downloadable resources will include a capnography cheat-sheet detailing different traces and their meaning, premedication drugs comparison tables and pre and post rabbit anaesthesia check-lists.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "We take great pride in our investment in educational initiatives to enable veterinary professionals to deliver best practice anaesthesia to their clients. The new Anaesthesia1ST newsletter further demonstrates our commitment to educational support resources to enable veterinary professionals to attain and maintain 1ST class anaesthesia for all patients."
To sign up to the Anaesthesia1ST newsletter, click here, visit the Alfaxan website – www.alfaxan.co.uk, contact your local Jurox technical sales representative or email Jurox at: info@jurox.co.uk.
The survey, which takes about 5 minutes (I timed it), is designed to canvas opinion about the priorities for learning and development.
Rich Casey, Junior Vice President of the VMG (pictured right), said: "From marketing to HR to financial planning and all points in between, today’s veterinary leaders require expertise in every aspect of running a successful business.
"We want to create a truly valuable, constructive and evidence-based CPD calendar for next year. Views from those working in the profession will help us to fully understand what good leadership and management look like in the veterinary world and we will then make sure that the programme promotes best practice in these important areas. We thank everyone who takes the time to complete the survey."
The survey can be accessed here: https://www.surveymonkey.co.uk/r/VETCPDPR
Cognitive aids are visual prompts that aim to reduce human error in critical processes by providing a supportive framework that ensures tasks are performed and communicated appropriately. They are designed for use whilst a task is being undertaken and enable individuals to concentrate on problem-solving and decision-making.
The BSAVA Cognitive Aids for Anaesthesia in Small Animal Practice, written by veterinary anaesthesia specialist Matt McMillan, includes both routine checklists, such as pre-anaesthetic assessment, equipment checks and postoperative handover, and crisis checklists for potential complications that may be encountered during surgery, such as hypotension, bradycardia and haemorrhage.
The guide also includes downloadable forms, which can be used in practice to ensure safety checks are completed and help improve clinical outcomes (available from www.bsavalibrary.com).
Ian Self, Principal Clinical Anaesthetist at the University of Cambridge Department for Veterinary Medicine said: "This handbook should be viewed as a ‘second pair of eyes’ throughout a procedure, especially if an anaesthetised patient deteriorates; consider it as having an experienced anaesthetist looking over your shoulder offering words of advice… I am very happy to endorse this exciting new BSAVA resource."
The BSAVA Cognitive Aids for Anaesthesia in Small Animal Practice is now available from the BSAVA website (www.bsava.com/shop) or by phone on 01452 726700 (£25; BSAVA members: £15).
The original editorial team of Daniel Brockman and David Holt has been joined by Gert ter Haar to produce a new edition which considers the substantial progress that has been made in this important field, including the challenges of treating airway abnormalities linked to brachycephalism, the constraints of complex bony anatomy and rich vascularity of the head when performing radical surgery, and the treatment of trauma.
The book includes a number of new techniques, including dorsal rhinotomy and total ear canal ablation.
The BSAVA says operative techniques, instructive photographs and full-colour illustrations remain a key feature of the manual, which is aimed at the general veterinary practitioner.
The BSAVA Manual of Canine and Feline Head, Neck and Thoracic Surgery, 2nd edition is available from the BSAVA website: www.bsava.com or by phone: 01452 726700.
Mr Antonovs faced three charges.
The first was that in September 2020 whilst in practice at Beverley Vets4Pets, he attended work when under the influence of alcohol.
The second was that between September and December 2020, whilst at Peel Veterinary Clinic, he attended work on two occasions when under the influence of alcohol.
The final charge was that between February 2021 and February 2023, Mr Antonovs failed to respond adequately to requests from the RCVS regarding concerns raised about his conduct and/or health.
Mr Antonovs admitted the facts of the charges and the Committee decided that the facts amounted to serious professional misconduct.
The Committee therefore decided, in the particular circumstances of this case, to impose a reprimand and warning as to his future conduct on the basis that it would be proportionate in order to maintain public confidence in the profession and uphold proper standards of conduct and behaviour.
The full details of the hearing and the Committee’s decision can be found at www.rcvs.org.uk/disciplinary
Virbac has launched Milpro, a palatable milbemycin / praziquantel-based broad-spectrum wormer for dogs and cats.
Milpro is offered in tablet sizes suitable for dogs, small dogs or puppies, cats and small cats or kittens for ease of dosing. It is presented in 4, 24 and 48 packs.
As an aid to owner education and compliance, packs of Milpro use 'Blippar Augmented Reality'. Owners download the Blippar app and scan the front of a pack of Milpro or a dispensing envelope, whereupon the pack becomes animated and various interactive options appear, including educational videos, a built in reminder system and other product information.
Simon Boulton MRCVS, Marketing Manager for Companion Animals at Virbac, said: "The practice team has a crucial role to play in reminding owners that regular worming is essential for their pet's health. With the introduction of Milpro, we are extending our parasiticide range and offering practices an alternative solution.
"With compliance such an issue, we want to use 21st century communication to help practices to get the message across. The result is the introduction of an interactive element to our packs with the use of the Blippar platform. It enables us to create 'Augmented Reality' experiences through which we can provide comprehensive information to owners in an eye-catching and easily accessible way with the aim of boosting compliance and, ultimately, welfare.
"We believe the combination of the small tablet sizes and the innovative packaging will prove attractive and convenient to owners, making Milpro a successful product for practices".
Practices can also request an interactive waiting room poster which enables owners to watch a video on the poster on the importance of worming.
Working in collaboration with researchers at University of Texas, Southwestern (UTSW) Medical Center, the team has succeeded in using gene editing techniques on dogs to restore the expression of the dystrophin protein that is absent in DMD patients’ muscles to levels that could be life changing.
DMD is the most common, fatal, genetic disease that affects children. The same disorder also occurs in many dog breeds. It is caused by mutations in the gene that encodes dystrophin, a crucial protein that helps protect muscle fibres and the heart when they contract. Patients with the disease produce effectively no dystrophin protein, so their muscles and heart become damaged during contraction, leading to inability to walk, skeletal deformities, breathing problems and heart failure. Patients with DMD have a life expectancy that does not go far beyond their twenties.
Researchers say that this preliminary research, published in Science, demonstrates an approach that could lead to an effective, in principle one-time treatment for DMD for the most common genetic mutations affecting human patients. Through a single intravenous injection, researchers have been able to modify the dystrophin gene in many muscles of the body, including the heart, with the result that some muscles now had almost the normal amounts of dystrophin protein.
The team, led by Eric Olson, Ph.D., professor and chair of the Department of Molecular Biology at UTSW Medical Center and founder and chief science advisor of Exonics Therapeutics, and Richard Piercy, Ph.D., MRCVS, Professor of Comparative Neuromuscular Disease at the RVC, identified a naturally-occurring mutation in the dystrophin gene in a dog brought to the RVC’s Small Animal Referral Hospital.
Working now with relatives of this first dog, the combined group has used a technique called ‘SingleCut CRISPR gene editing’, where the researchers target a specific region of the subject’s own DNA. Harmless viruses encoding the gene-editing protein CRISPR/Cas9 were used to express the enzyme in muscle to cut the dogs’ own DNA at a precise location in the dystrophin gene through use of a molecular guide. The body’s own processes then repair the cut, which results in removing the negative effects of the existing mutation.
The researchers have demonstrated that dogs treated in this way had restored ability to produce large amounts of the dystrophin protein in their muscles and heart, and in the dog with the highest dose, cardiac muscles were found to have restored dystrophin protein to up to 92% of normal amounts after the single treatment.
The team believes this is the first time that this form of gene editing therapy has been conducted after birth in an animal larger than a rodent. With further longer-term research, efficacy and safety testing, it is hoped that this breakthrough will have human application. This treatment may be a significant step toward developing a gene editing therapy to repair genetic mutations for DMD, as well as a range of diseases caused by genetic mutations.
Richard Piercy, Professor of Comparative Neuromuscular Disease at the RVC, said: "Researchers have been looking for an effective and durable treatment for Duchenne muscular dystrophy for many years. This SingleCut gene editing approach, pioneered by Dr. Eric Olson’s group, has the potential to be a one-time treatment that could restore dystrophin protein. It is hugely exciting that through a single intravenous injection we’ve been able successfully to modify the dogs’ own DNA so they start generating dystrophin protein again. There is more work to be done, but with this exciting breakthrough, we feel we are a significant step closer to finding an effective treatment.
"A great many genetic diseases affect humans, dogs and other species - many, like DMD - with tragic consequences and this form of gene editing treatment might well be applicable in many of them. We’re hopeful that we’re paving the way for future research into treating some of the most serious genetic conditions that affect us today."
Dr Stephen Hearns, a consultant in aeromedical retrieval (human) medicine, who delivers pre-hospital critical care for major trauma patients, will open Congress as the keynote speaker.
He'll also present a limited-seat session where he’ll focus on performance under pressure.
Joining Stephen in the speaker line up are Simon Cook from the RVC, Megan Brashear from Purdue University Veterinary Hospital, Tim Travail, Chloe Fay, Dan Tipney, Jenny Guyat, Ashton Hollworth and Dr Craig Joyce, an educational psychologist who will be offering his insights into dealing with imposter syndrome.
This year, participants will have the opportunity to follow a trauma case from arrival to departure on the first day of Congress, gaining real-time insights into the decision-making process and management strategies.
On day two, speakers will delve into lessons learned, allowing attendees to deepen their understanding of emergency and critical care practices
Simon said: “Get ready for a fantastic speaker line-up, an array of workshops and learning experiences, a bustling exhibition hall and more opportunities than ever for veterinary and nursing delegates to reconnect with old friends and make new ones.
"Brace yourselves to absorb knowledge and tips from some of the world’s leading veterinary experts discussing emergency and critical care.”
The ECC Congress programme for 2023 is open to veterinary professionals of all levels, including veterinarian surgeons, vet nurses, students and graduates.
Tickets range in price from £50+ VAT for exhibition-only tickets, up to £520+ VAT for a vet to attend for 2 days plus the Gala dinner.
https://www.vets-now.com/congress/
Running in July, the campaign aims to raise awareness of hyperthyroidism in cats and hypothyroidism in dogs, educate pet owners to spot the symptoms and thereby encourage early diagnosis.
MSD Animal Health says it hopes the campaign will increase the number of pets being taken to their veterinary practice for diagnosis, and increase both return visits and treatment compliance.
Practices supporting Pet Thyroid Month will be supplied with resources to help them educate pet owners about the two conditions.
Caroline Darouj, product manager at MSD Animal Health, said: "Although hyperthyroidism in cats and hypothyroidism in dogs are well known conditions and diagnosis is generally straightforward, a large number of vets in Europe state that both disorders are under-diagnosed, due to the fact that pet owners don’t recognise the signs.
"We wanted to launch our Thyroid Month campaign to encourage pet owners to spot the early symptoms of thyroid issues in their pets and seek advice from their veterinary practices.
"Our aim is also to benefit and educate vets and vet nurses with regard to the use of Leventa and Vidalta in treating these manageable conditions in both dogs and cats."
To find out more about Pet Thyroid Month, visit www.vidalta.co.uk
The expansion, which was completed last year, added a whole floor dedicated to emergency and critical care, a new specialist oncology treatment area and additional theatre space.
Davinia Arnott (pictured right), a European and RCVS Specialist in Small Animal Surgery, is leading the new residency programme. She said: "To be awarded the ability to run a residency, you have to be accredited to the highest possible standard, and there is a range of stringent ECVS criteria that we needed to meet.
"We were able to put ourselves forward following the expansion of our hospital and all the new facilities we have added. We are all really proud to be in a position to offer this new small animal surgical residency.
"We now have four theatres so we can do multiple surgeries at the same time, allowing us to greatly increase our caseload. We can also do fluoroscopy for orthopaedics and soft tissue. We just didn’t have that capability before.
"To achieve specialist status, the standard is exceptionally high so we’ll only have one resident every three years. This is to ensure they’re mentored and guided properly throughout."
Leo Roses is the first small animal surgery resident to join the new Vets Now programme. She began her three-year tenure in January after completing a surgical internship in the hospital. Leo, who is originally from Majorca and has also worked for Vets4Pets, Fitzpatrick and PDSA, is realising a long-held dream by embarking on a surgery residency.
She said: "I realised during my degree that I wanted to specialise in surgery. I did two surgical internships before coming to Glasgow to do a third. I applied for a position here because I was aware of the incredible reputation of the surgeons and had been told they were really keen to teach."
The awards are based on more than 11,000 pet owner reviews submitted to VetHelpDirect.com over the past 12 months.
The reviews cover 2,500 veterinary practices around the UK, with awards given to the practices with the highest number of four and five-star reviews from customers.
Tracey Morley Jewkes, Managing Director of Willows, said: “I am so proud of our team here and it’s fantastic to have won such a prestigious award based on client reviews.
"It was fabulous to receive such wonderful feedback as part of this award process. Our team at Willows is one of the best in the world, and we continue to strive for excellence in all that we do, providing the very highest standards of veterinary care to our patients, their owners and our referring vets."
Susie Samuel, managing director of VetHelpDirect.com, said: “The Best UK Vet awards are now in their eighth year and are a fantastic way to illustrate the strength of veterinary care in the UK.
“The awards are based on real-time customer reviews written over the past calendar year and recognise the very best veterinary practitioners.
“For animal owners, choosing a vet can be an anxious time, having access to reviews from other owners cuts down that anxiety. A vet who has been positively reviewed a number of times by different owners is clearly trusted and we know this provides peace of mind for new customers.
"The awards are categorised by geographical region, and also by type of practice and we have been delighted by the diversity of practices reviewed positively by their customers this year."
The silver award went to St Anne's Veterinary Group and the bronze award winning practice was Mayow Veterinary Surgery.
Photo: Toby Gemmill, Willows clinical director, Deputy Mayor of Solihull, Councillor Flo Nash, Tracey Morley Jewkes, managing director of Willows and Susie Samuels, founder and CEO VetHelpDirect
The Disciplinary Committee heard three charges against Dr Jones.
The first and second charges were that, in March 2018, Dr Jones made signed entries in the passports and made corresponding entries in clinical records of four horses indicating that he had administered an influenza vaccination booster to each horse on 15 March 2018 and in relation to another horse a tetanus booster, when in fact he had administered the vaccination boosters on 21 March 2018, and that his conduct was misleading, dishonest and undermined the integrity of a vaccination process designed to promote animal welfare.
The third charge was that, on or around 21 March 2018, Dr Jones failed to make any entries in the clinical records for a horse in relation to an examination on 21 March 2018.
At the outset of the hearing Dr Jones admitted the facts in the first and second charges, and accepted that his actions were misleading, dishonest and that they undermined the integrity of a vaccination process. However, he disputed certain aspects of the written statements of the College’s witnesses. In particular he wanted his conduct to be taken in the context of the pressures that he was working under on that day, primarily that he was in a stressed state having had to euthanase a valuable stallion at the conclusion of his previous client appointment.
Dr Jones did not admit the third charge, explaining that he did not remember examining the horse on 21 March 2018 as alleged.
Based on Dr Jones' own admissions, the Committee found the first and second charges proven.
Regarding the third charge, the Committee heard evidence from the horse’s owner who said they were present during the examination taking place and the Committee was satisfied that the respondent did examine the horse on 21 March 2018 and that he had a duty to make a brief clinical note on the examination. As Dr Jones admitted that he made no such note, the Committee found the charge to have been proven to the requisite standard.
Having found the charges proven, the Committee then went on to consider whether or not Dr Jones’ proven conduct amounted to serious professional misconduct. The Committee, having considered the aggravating and mitigating factors, found that Dr Jones’ conduct as found proved in relation to both charges one and two, did constitute serious professional misconduct.
However, with regards to charge three, the Committee accepted that the respondent simply forgot that he had examined the horse and, therefore, the Committee was not satisfied that the failure to compile a record entry covering the horse’s examination constituted serious professional misconduct.
The Committee then considered what sanction to impose on Dr Jones in relation to the facts found proven in charges one and two. In doing so it took into account the 78 written testimonials and 4 character witnesses called on behalf of Dr Jones.
Ian Green, who chaired the Committee and spoke on its behalf, said: "The Committee’s decision on sanction has been based on an acceptance that the respondent’s conduct on this occasion was out-of-character, as the evidence of his character witnesses and the contents of the letters submitted in his support by his clients and other veterinary colleagues assert. The Committee also accepts that the respondent self-reported himself to his employer and to the College and has made a full and frank admission of his wrongdoing.
"Consideration was given to whether the sanction of a reprimand and/or warning as to future conduct would adequately reflect the gravity of the misconduct, however, after careful reflection it was concluded that such a sanction could not be justified. The reason is that acts of falsification involve acts of dishonesty by a professional person acting in a professional capacity, and the gravity of the matter arises not simply from the dishonesty but also from the possible consequences of the false certification. It should be clearly understood by members of the veterinary profession that, in appropriate false certification cases, the sanction of removal from the Register is one which may well be imposed."
The Committee therefore decided that suspending Dr Jones from the Register for two months would be the most appropriate sanction.
Davies Veterinary Specialists (DVS), the Hertfordshire-based private small animal referral practice, has launched a pro bono scheme to help deliver the practice's multi-specialist care to deserving patients and clients.
All first opinion practices are eligible to apply for the scheme, which will allow an average of one patient per month to receive free treatment.
Clive Elwood, managing director of DVS said: "The DVS board was unanimous in its desire to introduce a pro bono scheme to help the needy, specifically those patients that are likely to achieve a full recovery following specialist care, but are otherwise precluded from referral because of their owners' particular circumstances."
Pro bono requests are open to all practices. They will be based on advocacy from the clinical head of the referring practice and on genuine need.
To find out more visit http://www.vetspecialists.co.uk/ or call Dr Clive Elwood on 01582 883950.
Miss Johnson was convicted at North Somerset Magistrates’ Court following a guilty plea of the offence of theft by employee in December 2023, after she stole buprenorphine belonging to Yatton Vets earlier that year.
She was sentenced to a fine of £120, a surcharge of £48, and costs of £85.
There were four further charges against Miss Johnson.
Charge one related to Miss Johnson stealing 5ml of methadone in December 2022 from her employer, Vets4Pets in Bristol, and injecting herself with the methadone.
The police investigated the incident and Miss Johnson accepted a conditional caution for the theft, the condition being she should attend a drug awareness course.
Charge two related to Miss Johnson dishonestly taking a syringe of methadone in August 2023 from her employer, the Langford Small Animal Hospital, and injecting herself with it.
Charge three related to two dates in September 2023 when she dishonestly took methadone, gabapentin and buprenorphine from Yatton Vets, her then employer, injecting herself with the buprenorphine and then working when unfit to do so.
Miss Johnson was later convicted of theft in relation to the buprenorphine (charge five).
Charge four related to an incident in November 2023, when Miss Johnson dishonestly took a syringe of buprenorphine from Bristol PDSA, for the purposes of self-administration, and was dishonest both to other members of staff and in the clinical records about the circumstances of taking the buprenorphine.
Charge five was in relation to Miss Johnson’s criminal conviction.
At the outset of the hearing, Miss Johnson admitted all charges in their entirety.
Having reviewed all the evidence and taken Miss Johnson’s admissions into account, the Committee found each of the charges proved.
After the criminal proceedings had finished and had been reported to the College, Miss Johnson wrote a letter expressing her deepest apologies to both the RCVS and the profession.
Within this she also made it clear that she took full responsibility for her actions.
In a later statement, she added that she had tried to use the experience to learn and improve in every aspect of her career and life and did not want to defend her behaviour.
Within this statement she also retracted a previous request to resign from the register, stating that she would accept any outcome to the investigation.
In deciding whether the proved charges amounted to serious professional misconduct, the Committee took the following aggravating factors into account:
The Committee identified no mitigating factors and concluded that for each of the individual charges Miss Johnson’s conduct fell far short of the conduct expected of a member of the profession and that each of the charges one to four amounted to serious professional misconduct.
In relation to charge five, the criminal conviction, the Committee noted that the nature and the circumstances of the offence involved dishonesty, abuse of her professional position regarding access to controlled drugs, breach of her employer’s trust, and that the misconduct took place notwithstanding an investigation by the police for similar conduct in December 2022.
The Committee therefore concluded that charge five rendered Miss Johnson unfit to practise.
When deciding on a sanction, the Committee took into account mitigating factors, which included:
The Committee found no further aggravating factors at this stage.
Kathryn Peaty, chairing the Committee and speaking on its behalf said: “The Committee considered that the overall misconduct proved so serious and was incompatible with remaining on the register.”
She added: “The Committee accepted that Miss Johnson was currently likely to be drug-free on the basis of her evidence and that of her referee, but it noted that independent testing proving she had been drug free for any period of time was not available to it.
"Furthermore, Miss Johnson had been unable to demonstrate that she had worked without any incident recently as she had accepted she had been dismissed from her recent job.
“Having taken into account all of the aggravating and mitigating factors, and balancing the public interest and the need to uphold and maintain standards within the profession, and having decided that Miss Johnson’s insight was limited, the Committee concluded that the sanction of ‘removal’ was the only proportionate sanction it could impose in this case.
"It also decided that such a sanction maintained public confidence in the veterinary profession, safeguarded animal welfare and protected the public from any future risk of repetition of similar behaviour.
“The Committee therefore directed that the Registrar remove Miss Johnson’s name from the register of veterinary nurses forthwith.”
The Legislative Reform Order (LRO) to reconstitute the RCVS disciplinary committees separately from its Council has come into force and has amended the Veterinary Surgeons Act 1966 (VSA).
The LRO brings the RCVS in line with regulatory best practice and, says the College, improves the independence of its disciplinary processes, marking a major step towards the College becoming a 'First Rate Regulator'.
The amendment made by the LRO requires that the RCVS Preliminary Investigation and Disciplinary Committees are made up of veterinary surgeons and lay members who are not RCVS Council members, and who are appointed independently. This ensures that the same group of people is not responsible for setting the rules, investigating complaints and adjudication.
The LRO also brings lay people formally into the Preliminary Investigation Committee and will allow the RCVS to increase the pool of people available to investigate complaints and sit on disciplinary hearings.
The first external members will join the Disciplinary and Preliminary Investigation Committees from July 2013. After a two-year transition period, members of the RCVS Council will become ineligible for membership of these committees.
RCVS Registrar, Gordon Hockey, said: "The LRO has been the culmination of many years hard work by the RCVS and Defra, with the support of the British Veterinary Association. At first glance the change that the LRO makes to the Act may appear minor, but the reform fundamentally improves the way the veterinary profession is regulated, and will help to ensure public confidence in the RCVS disciplinary processes."
In the study titled “Outcomes of treatments for keratomalacia in dogs and cats: a systematic review of the published literature including non-randomised controlled and non-controlled studies”, a systematic review of the current literature was undertaken to determine the evidence base for the various treatments of keratomalacia in dogs and cats.
The aim of the review was to assess the evidence base and identify recommended treatment(s) based on globe survival, visual outcome, and time to resolution (while maintaining a globe).
An online literature search found 18 relevant studies which were then reviewed and assigned a level of evidence base as described in the Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence Working Group.
Each study was assessed for type of study described (e.g. retrospective, prospective, controlled, random/non-random, cohort study, case series/study), the number of animals included, criteria for assessing outcome (e.g. vision, corneal clarity, anatomic repair) and duration of follow-up and time to resolution.
Systematic reviews of randomised trials, randomised trials or observational studies with dramatic effects would have provided the most reliable evidence on which to base recommendations for treatment(s) but none were available for inclusion.
Only one study was classified as level 3 evidence (non-randomised controlled trial) and considered the use of corneal cross-linking (CXL) in the treatment of keratomalacia.
Most studies were level four evidence reporting the outcome of a single treatment, with three prospective studies and seven retrospective studies.
The remaining seven studies were level five evidence (mechanism-based reasoning) and were considered not to provide good evidence for answering the particular study question.
The findings of the study suggest that the evidence for improved outcome of one proposed treatment over another proposed treatment for keratomalacia in dogs and/or cats is very weak.
A combination of treatments – both medical and surgical – may be the most appropriate depending on the individual case.
Studies utilising mechanism-based reasoning would suggest that medical treatment with anti-collagenase treatment is a minimum requirement for keratomalacia cases to prevent globe loss through perforation, with associated pain and suffering.
Nicola Di Girolamo, Editor of JSAP, said: “The findings of this study highlight once more the infrequency of randomised controlled trials in the veterinary literature, and the need for such studies to expand the evidence base in this field.
“Focussing on collecting available evidence in well-conducted systematic reviews is a critical step in order to improve accessibility of the literature for general practitioners and specialists alike.”
The full article can be found in the October issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13326. It is open access and can be freely accessed by anyone.
Photo courtesy BSAVA
Ceva Animal Health has added to its joint care range with the launch of Meloxidyl Oral Suspension for Cats, licensed for the treatment of musculoskeletal disorders and alleviation of post-operative pain.
Meloxidyl Oral Suspension for Cats is available in 15ml bottles containing 0.5mg/ml meloxicam. Each pack contains a tailored maintenance dosing syringe with a 'kg scale' for all sizes of cat. In addition, Meloxidyl's sweet tasting formulation helps to maximise ease of administration.
Meloxidyl Injection complements Ceva Animal Health's joint care range, which also includes Meloxidyl Injection for dogs and cats and Meloxidyl Oral Suspension for dogs.
For further information, please contact your Ceva Animal Health representative or call 01494 781510.
Lecture topics will include interesting cases, the importance of systematic abdominal technique, the challenge of becoming ultrasound competent within a primary referral setting, basic anaesthetic nerve blocks, using ultrasound for appropriate medical management, how CASE can support competency based veterinary ultrasound training and more.
The session will end with a debate on whether it is time for a formal / stand alone Veterinary Ultrasound training programme and who should accredit such courses.
Speakers include Natasha Dickinson from Cave Veterinary Specialists, Niamh Casey from Village Vets, Miguel Martinez from Northwest Veterinary Specialists, Will Humphreys from the University of Liverpool and Nuala Summerfield from Virtual Veterinary Specialists.
The day costs £75 (sounds like a steal, if you ask me), and you can register here: https://www.bmus.org/meeting-booking/ultrasound-2019/
Squamous cell carcinoma affects horses’ genitalia, eyes, or skin around the eyes. The tumours typically have a guarded to poor prognosis, and the therapeutic approaches available have variable success rates. Euthanasia on welfare grounds is necessary in a significant number of cases.
Before this new research was published, pathologists and researchers Dr Alejandro Suárez-Bonnet and Professor Simon Priestnall, both from the RVC, had already undertaken research which showed that equine squamous cell carcinoma affecting the penis frequently acquires the ability to degrade the extracellular matrix and become much more biologically aggressive2. This is known as ‘epithelial to mesenchymal transition’.
This new study, recently published in Scientific Reports, is the product of a multi-institutional effort, which used both “classical” anatomic histopathology assessment and artificial intelligence to demonstrate a correlation between chronic inflammation, equine papillomavirus infection and progression of equine penile squamous cell carcinoma.
Several additional cancer-related signalling molecules, which are important in researchers’ understanding of human penile cancer, were also studied and the results obtained will lead to a much better understanding and treatment of the cancer.
Simon Priestnall, Professor of Veterinary Anatomic Pathology at the Royal Veterinary College, said: “Equine squamous cell carcinoma is the second most common type of cancer in horses, with a variable prognosis, so we are delighted to have made this breakthrough that provides a greater understanding and can lead to more effective treatments for horses and their owners.
"The RVC has always recognised the value of collaboration, and Alejandro and I enjoyed working alongside the teams at KCL, the University of Edinburgh and UCL. This project shows what can be achieved when different organisations work together with a common aim and we hope the similarities between the tumour in horses and people can offer a true One Health benefit."
Dr Alejandro Suárez-Bonnet, Lecturer in Comparative Pathology at the Royal Veterinary College, said: "I am so pleased with the results of this study, which will hopefully pave the way for improved prognosis of horses diagnosed with equine squamous cell carcinoma.
"Our work is not over, however. Thanks to the help of a grant from the Horse Race Betting Levy, Simon and I are leading a Master’s degree project investigating equine penile, ocular and vulvar squamous cell carcinomas from a broader perspective.
"Our hope is to identify if variability exists between equine papillomavirus infectious status, morphological and microscopic difference, and cancer progression, with the aim of identifying potential therapeutic targets as well as diagnostic markers with prognostic implications for maximum benefit to the British equine population.”